The Pharmaceuticals Division of Novartis is recognized worldwide for the innovative products, services and solutions we provide to patients, physicians and healthcare organizations. This growing business is changing the way medicine is practiced by following the science to deliver the right treatment to the right patient at the right time.
Our products are concentrated in major therapeutic areas including:
The current product portfolio includes more than 40 key marketed products, many of which are leaders in their respective therapeutic areas. In 2011 we received a total of 15 approvals in the United States, Europe and Japan.
The product development pipeline has 135 projects in various stages of clinical development, including potential new products as well as potential new indications or formulations for existing products.
We are also committed to developing and commercializing evidence-driven diagnostic tests that improve physicians' ability to optimize patient outcomes.